Identification of genes expressed differentially in an in vitro human lung carcinogenesis model

Cancer Biology and Therapy

Volumn 5, Issue 6, 2006, Pages 665-673

  Lacroix, Ludovic ^a   Feng, Gang ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Carcinogenesis; Early detection; Epithelial cells; Gene expression; Immortalized cells; Lung cancer; Premalignant

Indexed keywords

ADENYLATE CYCLASE; ALPHA6 INTEGRIN; ANNEXIN A8; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CONNEXIN 26; CYTOKERATIN 14; CYTOKERATIN 19; CYTOKERATIN 5; DESMOPLAKIN; FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1; GALECTIN 7; GLUTATHIONE TRANSFERASE P1; GROWTH FACTOR; INTERLEUKIN 1 ALPHA; LACTATE DEHYDROGENASE ISOENZYME 5; LAMININ GAMMA 2; LIPOCORTIN 1; NICOTINAMIDE METHYLTRANSFERASE; PARATHYMOSIN; S100 A10 PROTEIN; S100 A11 PROTEIN; S100 A2 PROTEIN; S100 A8 PROTEIN; TUBULIN GAMMA 1; UBIQUITIN CONJUGATING ENZYME E2C; UNCLASSIFIED DRUG;

ARTICLE; CANCER PREVENTION; CANCER STAGING; CELL ADHESION; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EARLY DIAGNOSIS; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; UPREGULATION;

EID: 33745786599     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.6.2870     Document Type: Article

References (73)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30.
2. Mao L. Recent advances in the molecular diagnosis of lung cancer. Oncogene 2002; 21:6960-9.
3. Wardwell NR, Massion PP. Novel strategies for the early detection and prevention of lung cancer. Semin Oncol 2005; 32:259-68.
4. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002; 64:681-708.
5. Virmani AK, Fong KM, Kodagoda D, McIntire D, Hung J, Tonk V, Minna JD, Gazdar AF. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer 1998; 21:308-19.
6. Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, Gazdar AF. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999; 18:643-50.
7. Ponticiello A, Barra E, Giani U, Bocchino M, Sanduzzi A. P53 immunohistochemistry can identify bronchial dysplastic lesions proceeding to lung cancer: A prospective study. Eur Respir J 2000; 15:547-52.
8. Westra WH, Baas IO, Hruban RH, Askin FB, Wilson K, Offerhaus GJ, Slebos RJ. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 1996; 56:2224-8.
9. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 1998; 95:11891-6.
10. Xu XC, Lee JS, Lee JJ, Morice RC, Liu X, Lippman SM, Hong WK, Lotan R. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J Natl Cancer Inst 1999; 91:1317-21.
11. Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 1998; 58:5032-7.
12. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, Milchgrub S, Srivastava S, Piatyszek MA, Shay JW, Gazdar AF. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997; 57:2373-7.
13. Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions. Clin Cancer Res 1999; 5:243-50.
14. Montuenga LM, Mulshine JL. New molecular strategies for early lung cancer detection. Cancer Invest 2000; 18:555-63.
15. Petty RD, Nicolson MC, Kerr KM, Collie-Duguid E, Murray GI. Gene expression profiling in nonsmall cell lung cancer: From molecular mechanisms to clinical application. Clin Cancer Res 2004; 10:3237-48.
16. Meyerson M, Franklin WA, Kelley MJ. Molecular classification and molecular genetics of human lung cancers. Semin Oncol 2004; 31:4-19.
17. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, Altman RB, Brown PO, Botstein D, Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001; 98:13784-9.
18. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ, Meyerson M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001; 98:13790-5.
19. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8:816-24.
20. Akmaev V, Cook B, Dufault M, Zhang M, Zhang W, Guo M, Curran J, Han S, Sidransky D, Buetow K, Madden SL, Jen J. Molecular characteristics of nonsmall cell lung cancer. Proc Natl Acad Sci USA 2001; 98:15203-8.
21. Inamura K, Fujiwara T, Hoshida Y, Isagawa T, Jones MH, Virtanen C, Shimane M, Satoh Y, Okumura S, Nakagawa K, Tsuchiya E, Ishikawa S, Aburatani H, Nomura H, Ishikawa Y. Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and nonnegative matrix factorization. Oncogene 2005; 24:7105-13.
22. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 2004; 6:1-6.
23. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, Harris CC. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988; 48:1904-9.
24. Klein-Szanto AJ, Iizasa T, Momiki S, Garcia-Palazzo I, Caamano J, Metcalf R, Welsh J, Harris CC. A tobaccospecific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc Natl Acad Sci USA 1992; 89:6693-7.
25. Feng G, Xu X, Youssef EM, Lotan R. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Res 2001; 61:7999-8004.
26. Powell CA, Xu G, Filmus J, Busch S, Brody JS, Rothman PB. Oligonucleotide microarray analysis of lung adenocarcinoma in smokers and nonsmokers identifies GPC3 as a potential lung tumor suppressor. Chest 2002; 121:6S-7S.
27. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
28. An Q, Pacyna-Gengelbach M, Schluns K, Deutschmann N, Guo S, Gao Y, Zhang J, Cheng S, Petersen I. Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis. Int J Cancer 2003; 103:194-204.
29. Park JS, Noh DY, Kim SH, Kim SH, Kong G, Chang CC, Lee YS, Trosko JE, Kang KS. Gene expression analysis in SV40-immortalized human breast luminal epithelial cells with stem cell characteristics using a cDNA microarray. Int J Oncol 2004; 24:1545-58.
30. Borczuk AC, Gorenstein L, Walter KL, Assaad AA, Wang L, Powell CA. Nonsmall-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 2003; 163:1949-60.
31. Virtanen C, Ishikawa Y, Honjoh D, Kimura M, Shimane M, Miyoshi T, Nomura H, Jones MH. Integrated classification of lung tumors and cell lines by expression profiling. Proc Natl Acad Sci USA 2002; 99:12357-62.
32. Gerke V, Creutz CE, Moss SE. Annexins: Linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005; 6:449-61.
33. Sakaguchi M, Miyazaki M, Takaishi M, Sakaguchi Y, Makino E, Kataoka N, Yamada H, Namba M, Huh NH. S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 2003; 163:825-35.
34. Makino E, Sakaguchi M, Iwatsuki K, Huh NH. Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death. J Mol Med 2004; 82:612-20.
35. Hayes MJ, Moss SE. Annexins and disease. Biochem Biophys Res Commun 2004; 322:1166-70.
36. Wang H, Zhang Z, Li R, Ang KK, Zhang H, Caraway NP, Katz RL, Jiang F. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer. Int J Cancer 2005; 116:285-90.
37. Smith SL, Gugger M, Hoban P, Ratschiller D, Watson SG, Field JK, Betticher DC, Heighway J. S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary nonsmall cell lung carcinomas. Br J Cancer 2004; 91:1515-24.
38. Kondo A, Sakaguchi M, Makino E, Namba M, Okada S, Huh NH. Localization of S100C immunoreactivity in various human tissues. Acta Med Okayama 2002; 56:31-4.
39. Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005; 46:256-69.
40. Belkin AM, Stepp MA. Integrins as receptors for laminins. Microsc Res Tech 2000; 51:280-301.
41. Smith GJ, Morris C, Leigh D, Rhodes GC, Wong A. EGF-receptor and extracellular matrix changes in mouse pulmonary carcinogenesis. Exp Lung Res 1991; 17:327-40.
42. Sathyanarayana UG, Toyooka S, Padar A, Takahashi T, Brambilla E, Minna JD, Gazdar AF. Epigenetic inactivation of laminin-5-encoding genes in lung cancers. Clin Cancer Res 2003; 9:2665-72.
43. Sugiyama M, Speight PM, Prime SS, Watt FM. Comparison of integrin expression and terminal differentiation capacity in cell lines derived from oral squamous cell carcinomas. Carcinogenesis 1993; 14:2171-6.
44. Lin CS, Zhang K, Kramer R. Alpha 6 integrin is upregulated in step increments accompanying neoplastic transformation and tumorigenic conversion of human fibroblasts. Cancer Res 1993; 53:2950-3.
45. Hirschi KK, Xu CE, Tsukamoto T, Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 1996; 7:861-70.
46. Chen Y, Huhn D, Knosel T, Pacyna-Gengelbach M, Deutschmann N, Petersen I. Downregulation of connexin 26 in human lung cancer is related to promoter methylation. Int J Cancer 2005; 113:14-21.
47. Bernerd F, Sarasin A, Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci USA 1999; 96:11329-34.
48. Ueda S, Kuwabara I, Liu FT. Suppression of tumor growth by galectin-7 gene transfer. Cancer Res 2004; 64:5672-6.
49. Sauter ER, Nesbit M, Tichansky D, Liu ZJ, Shirakawa T, Palazzo J, Herlyn M. Fibroblast growth factor-binding protein expression changes with disease progression in clinical and experimental human squamous epithelium. Int J Cancer 2001; 92:374-81.
50. Wagner KW, Sapinoso LM, El-Rifai W, Frierson HF, Butz N, Mestan J, Hofmann F, Deveraux QL, Hampton GM. Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 2004; 23:6621-9.
51. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389:300-5.
52. Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson IInd RS, Wang M, Liang P. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 2004; 279:48930-40.
53. Trask DK, Band V, Zajchowski DA, Yaswen P, Suh T, Sager R. Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci USA 1990; 87:2319-23.
54. Bowden PE, Woodworth CD, Doniger J, DiPaolo JA. Downregulation of keratin 14 gene expression after v-Ha-ras transfection of human papillomavirus- immortalized human cervical epithelial cells. Cancer Res 1992; 52:5865-71.
55. Fuchs E, Tyner AL, Giudice GJ, Marchuk D, RayChaudhury A, Rosenberg M. The human keratin genes and their differential expression. Curr Top Dev Biol 1987; 22:5-34.
56. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 2000; 60:749-55.
57. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, Sager R. Downregulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci USA 1992; 89:2504-8.
58. Kerkhoff C, Sorg C, Tandon NN, Nacken W. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry 2001; 40:241-8.
59. Zobiack N, Gerke V, Rescher U. Complex formation and submembranous localization of annexin 2 and S100A10 in live HepG2 cells. FEBS Lett 2001; 500:137-40.
60. Seemann J, Weber K, Gerke V. Annexin I targets S100C to early endosomes. FEBS Lett 1997; 413:185-90.
61. Sakaguchi M, Miyazaki M, Inoue Y, Tsuji T, Kouchi H, Tanaka T, Yamada H, Namba M. Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts. J Cell Biol 2000; 149:1193-206.
62. Hawkins TE, Merrifield CJ, Moss SE. Calcium signaling and annexins. Cell Biochem Biophys 2000; 33:275-96.
63. Burdett ID. Aspects of the structure and assembly of desmosomes. Micron 1998; 29:309-28.
64. Jungmann RA, Huang D, Tian D. Regulation of LDH-A gene expression by transcriptional and posttranscriptional signal transduction mechanisms. J Exp Zool 1998; 282:188-95.
65. Singal R, van Wert J, Bashambu M. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Cancer Res 2001; 61:4820-6.
66. Varsano S, Rashkovsky L, Shapiro H, Radnay J. Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines. Am J Respir Cell Mol Biol 1998; 19:522-9.
67. Tassi E, Al-Attar A, Aigner A, Swift MR, McDonnell K, Karavanov A, Wellstein A. Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein. J Biol Chem 2001; 276:40247-53.
68. Chien J, Shah GV. Role of stimulatory guanine nucleotide binding protein (GSalpha) in proliferation of PC-3M prostate cancer cells. Int J Cancer 2001; 91:46-54.
69. Moritz M, Agard DA. Gamma-tubulin complexes and microtubule nucleation. Curr Opin Struct Biol 2001; 11:174-81.
70. Aksoy S, Szumlanski CL, Weinshilboum RM. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem 1994; 269:14835-40.
71. Byun Y, Chen F, Chang R, Trivedi M, Green KJ, Cryns VL. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ 2001; 8:443-50.
72. Bastians H, Topper LM, Gorbsky GL, Ruderman JV. Cell cycle-regulated proteolysis of mitotic target proteins. Mol Biol Cell 1999; 10:3927-41.
73. Vareli K, Frangou-Lazaridis M, van der Kraan I, Tsolas O, van Driel R. Nuclear distribution of prothymosin alpha and parathymosin: Evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replication. Exp Cell Res 2000; 257:152-61.